Applied BioCode Financials
| 6598 Stock | TWD 24.10 0.05 0.21% |
Applied |
Understanding current and past Applied BioCode Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Applied BioCode's financial statements are interrelated, with each one affecting the others. For example, an increase in Applied BioCode's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Applied BioCode's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Applied BioCode. Check Applied BioCode's Beneish M Score to see the likelihood of Applied BioCode's management manipulating its earnings.
Applied BioCode Stock Summary
Applied BioCode competes with Wellell, Medical Imaging, Golden Biotechnology, GlycoNex, and Ok Biotech. Applied BioCode Corporation designs, develops, manufactures, and commercializes multiplex testing products for the In-Vitro diagnostics market. The company was founded in 2016 and is based in Santa Fe Springs, California. APPLIED BIOCODE operates under Medical Devices classification in Taiwan and is traded on Taiwan Stock Exchange.| Instrument | Taiwan Stock View All |
| Exchange | Taiwan Stock Exchange |
| ISIN | KYG0488D1051 |
| Business Address | 12130 Mora Dr, |
| Sector | Healthcare |
| Industry | Medical Devices |
| Benchmark | Dow Jones Industrial |
| Website | www.apbiocode.com |
| Phone | 833 246 2633 |
| Currency | TWD - New Taiwan Dollar |
You should never invest in Applied BioCode without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Applied Stock, because this is throwing your money away. Analyzing the key information contained in Applied BioCode's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Applied BioCode Key Financial Ratios
There are many critical financial ratios that Applied BioCode's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Applied BioCode reports annually and quarterly.| Return On Equity | -0.19 | |||
| Return On Asset | -0.0936 | |||
| Number Of Employees | 11 | |||
| Beta | 0.45 | |||
| Z Score | 23.4 |
Applied Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Applied BioCode's current stock value. Our valuation model uses many indicators to compare Applied BioCode value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Applied BioCode competition to find correlations between indicators driving Applied BioCode's intrinsic value. More Info.Applied BioCode is rated third in return on equity category among its peers. It also is rated third in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Applied BioCode's earnings, one of the primary drivers of an investment's value.Applied BioCode February 3, 2026 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Applied BioCode help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Applied BioCode. We use our internally-developed statistical techniques to arrive at the intrinsic value of Applied BioCode based on widely used predictive technical indicators. In general, we focus on analyzing Applied Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Applied BioCode's daily price indicators and compare them against related drivers.
| Downside Deviation | 1.69 | |||
| Information Ratio | 0.0353 | |||
| Maximum Drawdown | 8.26 | |||
| Value At Risk | (2.52) | |||
| Potential Upside | 2.79 |
Additional Tools for Applied Stock Analysis
When running Applied BioCode's price analysis, check to measure Applied BioCode's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Applied BioCode is operating at the current time. Most of Applied BioCode's value examination focuses on studying past and present price action to predict the probability of Applied BioCode's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Applied BioCode's price. Additionally, you may evaluate how the addition of Applied BioCode to your portfolios can decrease your overall portfolio volatility.